Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12012433 Expression and purification of Cas enzymes

Patent 12012433 was granted and assigned to Integrated DNA Technologies on June, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Integrated DNA Technologies

Current Assignee

Integrated DNA Technologies

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

120124330

Patent Inventor Names

Christopher Anthony Vakulskas0

Michael Allen Collingwood0

Sarah Franz Beaudoin0

Mark Aaron Behlke0

Date of Patent

June 18, 2024

Patent Application Number

171857880

Date Filed

February 25, 2021

Patent Citations

‌

US Patent 10717978 None

‌

US Patent 7560529 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence

‌

US Patent 9790490 CRISPR enzymes and systems

‌

US Patent 9840702 CRISPR-based compositions and methods of use

‌

US Patent 10266886 CRISPR effector system based diagnostics

‌

US Patent 10767176 CRISPR-based compositions and methods of use

Patent Primary Examiner

CPC Code

Patent abstract

Described herein are methods for the expression and purification of Cas13a and methods for detecting target RNA using Cas13a.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12012433 Expression and purification of Cas enzymes

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API